Melanie M Taylor Selected Research

Syphilis

1/2021	Cost-effectiveness of dual maternal HIV and syphilis testing strategies in high and low HIV prevalence countries: a modelling study.
1/2021	Prevalence of syphilis among men who have sex with men: a global systematic review and meta-analysis from 2000-20.
1/2021	Treatment administered to newborns with congenital syphilis during a penicillin shortage in 2015, Fortaleza, Brazil.
1/2021	Prevalence assessment of sexually transmitted infections among pregnant women visiting an antenatal care center of Nepal: Pilot of the World Health Organization's standard protocol for conducting STI prevalence surveys among pregnant women.
6/2020	Phase II trial evaluating the clinical efficacy of cefixime for treatment of active syphilis in non-pregnant women in Brazil (CeBra).
1/2020	Effectiveness and Tolerability of Oral Amoxicillin in Pregnant Women with Active Syphilis, Japan, 2010-2018.
12/2019	Syphilis management in pregnancy: a review of guideline recommendations from countries around the world.
1/2019	Global burden of maternal and congenital syphilis and associated adverse birth outcomes-Estimates for 2016 and progress since 2012.
1/2019	Field performance evaluation of dual rapid HIV and syphilis tests in three antenatal care clinics in Zambia.
1/2019	Syphilis diagnosis and treatment during antenatal care: the potential catalytic impact of the dual HIV and syphilis rapid diagnostic test.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Melanie M Taylor Research Topics

Disease

20	Syphilis 01/2021 - 02/2007
7	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2022 - 02/2007
4	Congenital Syphilis (Hutchinson's Teeth) 01/2021 - 01/2016
3	HIV Infections (HIV Infection) 11/2014 - 04/2005
2	COVID-19 10/2022 - 01/2021
2	Infections 06/2020 - 05/2005
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022
1	Trichomonas Infections 01/2021
1	Hepatomegaly 01/2021
1	Jaundice (Icterus) 01/2021
1	tertiary Syphilis 01/2020
1	Gonorrhea 01/2018
1	Urethritis 01/2018
1	Pregnancy Complications 01/2016
1	Stillbirth 01/2016
1	Perinatal Death 01/2016
1	HIV Seropositivity 04/2005

Drug/Important Bio-Agent (IBA)

6	Penicillin G Benzathine (Benzathine Benzylpenicillin)FDA Link 01/2022 - 01/2016
4	Penicillins (Penicillin)FDA Link 01/2021 - 01/2016
3	Biological ProductsIBA 01/2021 - 11/2014
2	Potassium Iodide (Pima)FDA Link 01/2016 - 01/2016
1	VaccinesIBA 10/2022
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021
1	Ivermectin (Mectizan)FDA Link 01/2021
1	remdesivirIBA 01/2021
1	VitaminsIBA 01/2021
1	Interferon-betaIBA 01/2021
1	Ritonavir (Norvir)FDA Link 01/2021
1	Lopinavir FDA Link 01/2021
1	Cefixime (Suprax)FDA Link 06/2020
1	Third Generation CephalosporinsIBA 06/2020
1	Ampicillin (Omnipen)FDA LinkGeneric 01/2020
1	Amoxicillin (Wymox)FDA LinkGeneric 01/2020
1	GoldIBA 01/2019
1	Dihydrotachysterol (AT 10)IBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2017
1	Methamphetamine (Desoxyn)FDA LinkGeneric 02/2007
1	DNA (Deoxyribonucleic Acid)IBA 01/2007
1	Pharmaceutical PreparationsIBA 05/2005
1	EnzymesIBA 04/2005

Therapy/Procedure

11	Prenatal Care (Care, Prenatal) 01/2021 - 08/2011
2	Therapeutics 01/2021 - 12/2019
2	Injections 01/2020 - 01/2016
1	Phototherapy (Light Therapy) 01/2021
1	Complementary Therapies (Alternative Medicine) 06/2020
1	Time-to-Treatment 01/2016